Cite
HARVARD Citation
Colombo, N. et al. (n.d.). 392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study. International journal of gynecological cancer. pp. A76-A77. [Online].